Synthetic TRuC receptors engaging the complete T cell receptor for potent anti-tumor response

T cells expressing CD19-targeting chimeric antigen receptors (CARs) reveal high efficacy in the treatment of B cell malignancies. Here, we report that T cell receptor fusion constructs (TRuCs) comprising an antibody-based binding domain fused to T cell receptor (TCR) subunits can effectively reprogr...

Descripción completa

Detalles Bibliográficos
Autores principales: Baeuerle, Patrick A., Ding, Jian, Patel, Ekta, Thorausch, Niko, Horton, Holly, Gierut, Jessica, Scarfo, Irene, Choudhary, Rashmi, Kiner, Olga, Krishnamurthy, Janani, Le, Bonnie, Morath, Anna, Baldeviano, G. Christian, Quinn, Justin, Tavares, Patrick, Wei, Qi, Weiler, Solly, Maus, Marcela V., Getts, Daniel, Schamel, Wolfgang W., Hofmeister, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504948/
https://www.ncbi.nlm.nih.gov/pubmed/31064990
http://dx.doi.org/10.1038/s41467-019-10097-0

Ejemplares similares

Ejemplares similares